Samuel R. Denmeade

Samuel R. Denmeade

Corporate Officer/Principal at The Sidney Kimmel Comprehensive Cancer Center

Health Technology
Consumer Services
Health Services

Profile

Samuel R.
Denmeade
is the founder of Rebus Holdings, Inc. founded in 2003.
Currently, he is a Professor at The Johns Hopkins University and a Member-Chemical Therapeutics Program at The Sidney Kimmel Comprehensive Cancer Center.
Previously, he worked as the Chief Scientific Officer at Sophiris Bio, Inc. and Medicenna Therapeutics Corp.
in 2017.
He completed his undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.

Samuel R. Denmeade active positions

CompaniesPositionStart
Corporate Officer/Principal -
The Johns Hopkins University Corporate Officer/Principal -
All active positions of Samuel R. Denmeade

Former positions of Samuel R. Denmeade

CompaniesPositionEnd
MEDICENNA THERAPEUTICS CORP. Chief Tech/Sci/R&D Officer 2017-07-16
REBUS HOLDINGS, INC. Founder -
SOPHIRIS BIO Chief Tech/Sci/R&D Officer -
See the detail of Samuel R. Denmeade's experience

Training of Samuel R. Denmeade

The Trustees of Columbia University in The City of New York Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Samuel R. Denmeade's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
REBUS HOLDINGS, INC.

Health Technology

MEDICENNA THERAPEUTICS CORP.

Health Technology

Private companies2

Health Technology

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Samuel R. Denmeade